Kathmere Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Kathmere Capital Management's AMGN Position: Q3 2026 in Review
Kathmere Capital Management increased its Amgen (AMGN) stake by 7.2% in Q3 2026, buying an estimated $110K and bringing the position to 4,072 shares worth $1.72M. The position accounts for 0.08% of the portfolio, ranked #174.
Kathmere Capital Management first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Kathmere Capital Management held 4,072 shares of Amgen worth $1.72M as of Q3 2026.
- Kathmere Capital Management bought 275 Amgen shares in Q3 2026, an estimated $110K.
- Amgen made up 0.08% of Kathmere Capital Management's portfolio in Q3 2026, its #174 holding.
- Kathmere Capital Management first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Kathmere Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.